Literature DB >> 23884316

Long-term survival of type XVII collagen revertant cells in an animal model of revertant cell therapy.

Antoni Gostyński1, Sara Llames2, Marta García3, María J Escamez4, Lucía Martinez-Santamaria3, Miranda Nijenhuis5, Alvaro Meana2, Hendri H Pas5, Fernando Larcher4, Anna M G Pasmooij5, Marcel F Jonkman5, Marcela Del Rio3.   

Abstract

Mesh：

Substances：

Year:  2013        PMID： 23884316     DOI： 10.1038/jid.2013.308

Source DB:  PubMed          Journal:  J Invest Dermatol        ISSN： 0022-202X            Impact factor:   8.551


× No keyword cloud information.
  13 in total

1.  First symposium on natural gene therapy of the skin.

Authors:  Anna M G Pasmooij; Marcel F Jonkman
Journal:  Exp Dermatol       Date:  2012-03       Impact factor: 3.960

2.  Collagen XVII (BP180) modulates keratinocyte expression of the proinflammatory chemokine, IL-8.

Authors:  Françoise Van den Bergh; Steven L Eliason; Brian T Burmeister; George J Giudice
Journal:  Exp Dermatol       Date:  2012-08       Impact factor: 3.960

3.  Natural gene therapy may occur in all patients with generalized non-Herlitz junctional epidermolysis bullosa with COL17A1 mutations.

Authors:  Anna M G Pasmooij; Miranda Nijenhuis; Renske Brander; Marcel F Jonkman
Journal:  J Invest Dermatol       Date:  2012-02-09       Impact factor: 8.551

4.  Revertant mosaicism--patchwork in the skin.

Authors:  Marcel F Jonkman; Anna M G Pasmooij
Journal:  N Engl J Med       Date:  2009-04-16       Impact factor: 91.245

5.  Type XVII collagen regulates lamellipod stability, cell motility, and signaling to Rac1 by targeting bullous pemphigoid antigen 1e to alpha6beta4 integrin.

Authors:  Kevin J Hamill; Susan B Hopkinson; Marcel F Jonkman; Jonathan C R Jones
Journal:  J Biol Chem       Date:  2011-06-03       Impact factor: 5.157

6.  Receptor activator of NF-kappaB (RANK) stimulates the proliferation of epithelial cells of the epidermo-pilosebaceous unit.

Authors:  Vincent Duheron; Estelle Hess; Monique Duval; Marion Decossas; Beatriz Castaneda; Jennifer E Klöpper; Leonela Amoasii; Jean-Baptiste Barbaroux; Ifor R Williams; Hideo Yagita; Josef Penninger; Yongwon Choi; Frédéric Lézot; Richard Groves; Ralf Paus; Christopher G Mueller
Journal:  Proc Natl Acad Sci U S A       Date:  2011-03-14       Impact factor: 11.205

7.  Clinical results of an autologous engineered skin.

Authors:  Sara Llames; Eva García; Verónica García; Marcela del Río; Fernando Larcher; Jose Luis Jorcano; Eva López; Purificación Holguín; Francisca Miralles; Jesús Otero; Alvaro Meana
Journal:  Cell Tissue Bank       Date:  2006       Impact factor: 1.522

8.  Human plasma as a dermal scaffold for the generation of a completely autologous bioengineered skin.

Authors:  Sara G Llames; Marcela Del Rio; Fernando Larcher; Eva García; Marta García; María José Escamez; Jose L Jorcano; Purificación Holguín; Alvaro Meana
Journal:  Transplantation       Date:  2004-02-15       Impact factor: 4.939

9.  Adhesive stripping to remove epidermis in junctional epidermolysis bullosa for revertant cell therapy.

Authors:  A Gostynski; F C L Deviaene; A M G Pasmooij; H H Pas; M F Jonkman
Journal:  Br J Dermatol       Date:  2009-03-26       Impact factor: 9.302

10.  Expression of murine epidermal differentiation markers is tightly regulated by restricted extracellular calcium concentrations in vitro.

Authors:  S H Yuspa; A E Kilkenny; P M Steinert; D R Roop
Journal:  J Cell Biol       Date:  1989-09       Impact factor: 10.539
View more
  4 in total

Review 1.  Novel insights into the function and dynamics of extracellular matrix in liver fibrosis.

Authors:  Morten A Karsdal; Tina Manon-Jensen; Federica Genovese; Jacob H Kristensen; Mette J Nielsen; Jannie Marie B Sand; Niels-Ulrik B Hansen; Anne-Christine Bay-Jensen; Cecilie L Bager; Aleksander Krag; Andy Blanchard; Henrik Krarup; Diana J Leeming; Detlef Schuppan
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2015-03-12       Impact factor: 4.052

Review 2.  From marrow to matrix: novel gene and cell therapies for epidermolysis bullosa.

Authors:  Beau R Webber; Jakub Tolar
Journal:  Mol Ther       Date:  2015-03-24       Impact factor: 11.454

3.  [The many facets of inherited skin fragility].

Authors:  C Has; D Kiritsi
Journal:  Hautarzt       Date:  2014-06       Impact factor: 0.751

Review 4.  Advances in understanding and treating dystrophic epidermolysis bullosa.

Authors:  Michael J Vanden Oever; Jakub Tolar
Journal:  F1000Prime Rep       Date:  2014-05-06
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.